Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115 von Sanchorawala, V, Hoering, A, Seldin, D C, Finn, K T, Fennessey, S A, Sexton, R, Mattar, B, Safah, H F, Holmberg, L A, Dean, R M, Orlowski, R Z, Barlogie, B

Volltext

Hospital admissions following outpatient administration of high-dose melphalan and autologous SCT for AL amyloidosis von Freeman, B, Brauneis, D, Seldin, D C, Quillen, K, Sloan, J M, Renteria, A S, Shelton, A C, Teschner, T, Finn, K T, Sanchorawala, V

Volltext

A second course of high-dose melphalan and auto-SCT for the treatment of relapsed AL amyloidosis von Quillen, K, Seldin, D C, Finn, K T, Sanchorawala, V

Volltext

Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis von SANCHORAWAIA, V, WRIGHT, D. G, QUIIIEN, K, FINN, K. T, DEMBER, L. M, BERK, J. L, DOROS, G, FISHER, C, SKINNER, M, SEIDIN, D. C

Volltext

Treatment-Related Mortality in Patients with AL Amyloidosis Undergoing High-Dose Melphalan and Stem Cell Transplantation: Trend Over The Past 14 Years at a Single Institution von Sanchorawala, V, Skinner, M, Finn, K.T, Quillen, K, Seldin, D.C

Volltext

Bortezomib And High Dose Melphalan Followed By Autologous Stem Cell Transplantation (B-HDM/SCT) For The Treatment Of Al Amyloidosis: Results Of A Feasibility Study von Sanchorawala, V, Yanarella, L, Quillen, K, Sloan, J.M, Andrea, N.T, Finn, K.T, Seldin, D.C

Volltext

Febrile reactions occurring with second cycle of high-dose melphalan and SCT in patients with AL amyloidosis: a 'melphalan recall' reaction von Rosenzweig, M, Seldin, D C, Remick, D G, Skinner, M, Quillen, K, Oran, B, Finn, K T, Sanchorawala, V

Volltext

Clinical Pathways and Standard Operating Procedures: Essential Tools for Outpatient Stem Cell Transplant Programs Treating Patients With AL Amyloidosis von Finn, K.T, Fennessey, S, Yanarella, L, Antonelli, C, Shelton, A, Daniel, S, Skinner, M, Seldin, D, Quillen, K, Sanchorawala, V

Volltext

Febrile Reactions Occurring With Second Cycle of High Dose Melphalan and Stem Cell Transplantation in Patients With AL Amyloidosis: A “Melphalan Recall” Reaction von Rosenzweig, M.A, Seldin, D.C, Remick, D, Skinner, M, Quillen, K, Oran, B, Finn, K.T, Sanchorawala, V

Volltext

Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis von Dember, L.M, Skinner, M, Fisher, C, Sanchorawala, V, Doros, G, Wright, D.G, Berk, J.L, Quillen, K, Finn, K.T, Seldin, D.C

Volltext

A retrospective comparison of the impact of darbepoetin or epoetin usage on red cell transfusions transfusions in autologous stem cell transplantation (SCT) for light-chain related... von Baribeault, D.M., Finn, K.T., Kunz, R., Seldin, D.C., Sanchorawala, V.

Volltext

A retrospective analysis of the impact of erythropoeitic growth factor utilization on transfusion requirements in patients with AL amyloidosis undergoing autologous SCT von Baribeault, D.M., Shah, B., Finn, K.T., Seldin, D.C., Quillen, K., Sanchorawala, V.

Volltext

Cryotherapy (ice chips) is effective in preventing melphalan-induced oral mucositis (OM) in patients with AL amyloidosis von Finn, K.T., Sanchorawala, V., Kunz, R., Seldin, D., Wilkes, G., Oran, B.

Volltext

Accurate measurement of nanofluid thermal conductivity by use of a polysaccharide stabilising agent von Ebrahimi, R., de Faoite, D., Finn, D.P., Stanton, K.T.

Volltext

Molecular analysis of C3 allotypes in Chinese patients with immunoglobulin A nephropathy von FINN, J. E, LI, P. K. T, KAR NENG LAI, MATHIESON, P. W

Volltext